carbon monoxide has been researched along with Chronic Lung Injury in 15 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lung ischemia-reperfusion injury (IRI) may be attenuated through carbon monoxide (CO)'s anti-inflammatory effect or hydrogen (H2)'s anti-oxidant effect." | 7.83 | Protection of donor lung inflation in the setting of cold ischemia against ischemia-reperfusion injury with carbon monoxide, hydrogen, or both in rats. ( Cui, X; Jiang, C; Kang, J; Liu, J; Liu, R; Ma, L; Meng, C; Niu, L; Xing, J; Zhou, H, 2016) |
| "Lung ischemia-reperfusion injury (IRI) may be attenuated through carbon monoxide (CO)'s anti-inflammatory effect or hydrogen (H2)'s anti-oxidant effect." | 3.83 | Protection of donor lung inflation in the setting of cold ischemia against ischemia-reperfusion injury with carbon monoxide, hydrogen, or both in rats. ( Cui, X; Jiang, C; Kang, J; Liu, J; Liu, R; Ma, L; Meng, C; Niu, L; Xing, J; Zhou, H, 2016) |
| "We sought to determine whether ventilation of lungs after death in non-heart-beating donors with carbon monoxide during warm ischemia and ex vivo lung perfusion and after transplant would reduce ischemia-reperfusion injury and improve lung function." | 3.79 | Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors. ( Dong, B; Egan, TM; Stewart, PW, 2013) |
| " Although the effectiveness of HbVs, including their physicochemical characteristics and pharmacological effects, has been reported, data on the pharmacokinetic properties of HbVs are limited." | 2.58 | [Safety Evaluation of Cellular-type Artificial Blood Based on Pharmacokinetic Analysis and Its Use in Medical Gas Delivery]. ( Taguchi, K, 2018) |
| "Chronic obstructive pulmonary disease (COPD) is a disease involving airways restriction, alveolar destruction, and loss of lung function, primarily due to cigarette smoke (CS) exposure." | 2.48 | Heme Oxygenase-1/CO as protective mediators in cigarette smoke- induced lung cell injury and chronic obstructive pulmonary disease. ( Choi, AM; Dolinay, T; Ryter, SW, 2012) |
| "Although many diseases, including cancer, hematological diseases, hypertension, heart failure, inflammation, sepsis, neurodegeneration, and sleep disorders, have been linked to abnormal endogenous CO metabolism and functions, CO administration has therapeutic potential in inflammation, sepsis, lung injury, cardiovascular diseases, transplantation, and cancer." | 2.48 | Carbon monoxide: an unusual drug. ( Ascenzi, P; di Masi, A; Gullotta, F, 2012) |
| "Carbon monoxide (250 ppm) was given for 1 hour after termination of CPB." | 1.37 | Postconditioning of the lungs with inhaled carbon monoxide after cardiopulmonary bypass in pigs. ( Brehm, K; Goebel, U; Loop, T; Priebe, HJ; Schibilsky, D; Schlensak, C; Schwer, CI; Siepe, M, 2011) |
| "In a model of acute lung injury in mice, CO blocked expression of Egr-1, a central mediator of inflammation, and decreased tissue damage; inhibition of PPARgamma abrogated both effects." | 1.33 | Carbon monoxide orchestrates a protective response through PPARgamma. ( Bach, FH; Bilban, M; Chin, BY; d'Avila, JC; Esterbauer, H; Ifedigbo, E; Otterbein, LE; Otterbein, SL; Robson, SC; Usheva, A; Wagner, O, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HJ | 1 |
| Lee, SY | 2 |
| Park, D | 1 |
| Ryu, SH | 1 |
| Yoon, J | 1 |
| Jung, S | 1 |
| Lee, E | 1 |
| Yang, SI | 1 |
| Hong, SJ | 1 |
| Taguchi, K | 1 |
| Maignan, M | 1 |
| Briot, R | 1 |
| Romanini, D | 1 |
| Gennai, S | 1 |
| Hazane-Puch, F | 1 |
| Brouta, A | 1 |
| Debaty, G | 1 |
| Ventrillard, I | 1 |
| Meng, C | 1 |
| Ma, L | 1 |
| Niu, L | 1 |
| Cui, X | 1 |
| Liu, J | 1 |
| Kang, J | 1 |
| Liu, R | 1 |
| Xing, J | 1 |
| Jiang, C | 1 |
| Zhou, H | 1 |
| Smith-Sivertsen, T | 1 |
| Díaz, E | 1 |
| Pope, D | 1 |
| Lie, RT | 1 |
| Díaz, A | 1 |
| McCracken, J | 1 |
| Bakke, P | 1 |
| Arana, B | 1 |
| Smith, KR | 1 |
| Bruce, N | 1 |
| Goebel, U | 1 |
| Siepe, M | 1 |
| Schwer, CI | 1 |
| Schibilsky, D | 1 |
| Brehm, K | 1 |
| Priebe, HJ | 1 |
| Schlensak, C | 1 |
| Loop, T | 1 |
| Dolinay, T | 1 |
| Choi, AM | 1 |
| Ryter, SW | 1 |
| Gullotta, F | 1 |
| di Masi, A | 1 |
| Ascenzi, P | 1 |
| Dong, B | 1 |
| Stewart, PW | 1 |
| Egan, TM | 1 |
| Zolak, JS | 1 |
| Jagirdar, R | 1 |
| Surolia, R | 1 |
| Karki, S | 1 |
| Oliva, O | 1 |
| Hock, T | 1 |
| Guroji, P | 1 |
| Ding, Q | 1 |
| Liu, RM | 1 |
| Bolisetty, S | 1 |
| Agarwal, A | 1 |
| Thannickal, VJ | 1 |
| Antony, VB | 1 |
| Zhang, X | 1 |
| Shan, P | 1 |
| Alam, J | 1 |
| Davis, RJ | 1 |
| Flavell, RA | 1 |
| Lee, PJ | 1 |
| Kim, YJ | 2 |
| Bilban, M | 1 |
| Bach, FH | 1 |
| Otterbein, SL | 1 |
| Ifedigbo, E | 1 |
| d'Avila, JC | 1 |
| Esterbauer, H | 1 |
| Chin, BY | 1 |
| Usheva, A | 1 |
| Robson, SC | 1 |
| Wagner, O | 1 |
| Otterbein, LE | 2 |
| Sun, BW | 1 |
| Chen, X | 1 |
| Chen, ZY | 1 |
| Katada, K | 1 |
| Cepinskas, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Particulate Air Pollution Exposure and Childhood Acute Respiratory Infections in Guatemala: A Randomized Intervention[NCT01047696] | 537 participants (Actual) | Interventional | 2002-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for carbon monoxide and Chronic Lung Injury
| Article | Year |
|---|---|
[Safety Evaluation of Cellular-type Artificial Blood Based on Pharmacokinetic Analysis and Its Use in Medical Gas Delivery].
Topics: Acute Disease; Animals; Blood Substitutes; Carbon Monoxide; Disease Models, Animal; Drug Carriers; D | 2018 |
Heme Oxygenase-1/CO as protective mediators in cigarette smoke- induced lung cell injury and chronic obstructive pulmonary disease.
Topics: Animals; Carbon Monoxide; Heme Oxygenase-1; Humans; Lung Injury; Pulmonary Disease, Chronic Obstruct | 2012 |
Carbon monoxide: an unusual drug.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Enzyme Induction; Heme Oxygenase-1; Humans; Infla | 2012 |
Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule.
Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Monoxide; Cell Hypoxia; Disease | 2002 |
1 trial available for carbon monoxide and Chronic Lung Injury
| Article | Year |
|---|---|
Effect of reducing indoor air pollution on women's respiratory symptoms and lung function: the RESPIRE Randomized Trial, Guatemala.
Topics: Adolescent; Adult; Air Pollution, Indoor; Carbon Monoxide; Confidence Intervals; Cooking; Cooking an | 2009 |
10 other studies available for carbon monoxide and Chronic Lung Injury
| Article | Year |
|---|---|
Early-life exposure to humidifier disinfectant determines the prognosis of lung function in children.
Topics: Carbon Monoxide; Case-Control Studies; Child; Disinfectants; Female; Follow-Up Studies; Forced Expir | 2019 |
Real-time measurements of endogenous carbon monoxide production in isolated pig lungs.
Topics: Animals; Carbon Monoxide; Heme Oxygenase-1; Lasers; Lung; Lung Injury; Monitoring, Physiologic; Repe | 2014 |
Protection of donor lung inflation in the setting of cold ischemia against ischemia-reperfusion injury with carbon monoxide, hydrogen, or both in rats.
Topics: Animals; Apoptosis; Blood Gas Analysis; Carbon Monoxide; Cold Ischemia; Drug Synergism; Hydrogen; In | 2016 |
Postconditioning of the lungs with inhaled carbon monoxide after cardiopulmonary bypass in pigs.
Topics: Administration, Inhalation; Animals; Apoptosis; Biopsy; Carbon Monoxide; Cardiopulmonary Bypass; Cas | 2011 |
Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.
Topics: Animals; Blotting, Western; Carbon Monoxide; Cyclic GMP; Enzyme-Linked Immunosorbent Assay; Extracel | 2013 |
Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury.
Topics: Administration, Inhalation; Animals; Biomarkers; Carbon Monoxide; Cell Differentiation; Cell Movemen | 2013 |
Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury.
Topics: Animals; Apoptosis; Carbon Monoxide; Caspase 3; Caspase 8; Caspase 9; Caspases; Cytochrome c Group; | 2003 |
Role of crosslinked protein in lung injury following total body irradiation and bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Carbon Monoxide; Factor XIII; Female; Lung; Lung Injury; Mice; | 2003 |
Carbon monoxide orchestrates a protective response through PPARgamma.
Topics: Animals; Blotting, Western; Carbon Monoxide; Disease Models, Animal; Early Growth Response Protein 1 | 2006 |
[Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice].
Topics: Animals; Blotting, Western; Burns; Carbon Monoxide; Cell Adhesion; Disease Models, Animal; Electroph | 2007 |